2006, Anxiety disorders and Manufacturing

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2006

Anxiety disorders

Manufacturing

Branding Diseases—How Drug Companies Market Psychiatric Conditions: An Interview with Ray Moynihan

Mad in America

OCTOBER 18, 2023

Dhar: Is this what inspired you to create the “documentary” for ‘Motivational Deficiency Disorder’ and the April Fool piece in BMJ along with it? It was a fun thing to do, and we launched it in the British Medical Journal on April 1 st , 2006. We investigated social anxiety disorder. What was that about?

Pharmaceuticals

Pharmaceuticals Manufacturing Healthcare Neurotransmitters and mental health

STAR*D: The Harms of Orchestrated Psychiatric Fraud

Mad in America

SEPTEMBER 18, 2024

At a cost of 35 million dollars, NIMH’s STAR*D study, which was published in 2006 , is the most extensive and expensive study ever conducted to determine the effectiveness of drug treatment for depression. We showed how STAR*D’s authors had manipulated the data to manufacture fraudulent results.

Aging and mental health

Aging and mental health Cognitive Behavioral Therapy Manufacturing Anxiety disorders

Mental Health Clinicians

Branding Diseases—How Drug Companies Market Psychiatric Conditions: An Interview with Ray Moynihan

STAR*D: The Harms of Orchestrated Psychiatric Fraud

Stay Connected